Organon - M&A Summary and Business Overview

Healthcare ServicesCompany

Organon M&A Summary

Organon has acquired 2 companies, including 2 in the last 5 years.

Organon’s largest acquisition to date was in 2021, when it acquired Alydia Health for $240M. Organon has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (50%) and medical products (50%).

Organon Business Overview

Where is Organon headquartered?

Organon is headquartered in Jersey City, New Jersey.

What is Organon’s revenue?

Organon disclosed revenue of 8,096M USD for 2020 and 9,530M USD for 2019.

What sector is Organon in?

Organon is a healthcare services company.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 2

Organon

Organon & Co.

30 Hudson Street,
Jersey City, New Jersey 07302
United States,
(551) 430-6000
www.organon.com

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. The company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast-growing international markets. Organon is based in Jersey City, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # - - 2 - - - 2
vol $315M $315M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Forendo Pharma Ltd. 2021-11-11 75M USD Add-on Acquisition
Turku, Finland · www.forendo.com
Alydia Health, Inc. 2021-06-16 240M USD Add-on Acquisition
Menlo Park, California · www.alydiahealth.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (50%) 75M (24%) - -
Medical Products 1 (50%) 240M (76%) - -
Total 2 $315M - -

By Geo

State/Country Buy Value Sell Value
Finland 1 75M - -
United States 1 240M - -
  California 1 240M - -
Domestic 1 (50%) 240M (76%) - -
Cross-border 1 (50%) 75M (24%) - -
Total 2 $315M - -

Deal Values

buy # Total
$100M to $1B 1 $240M
< $100M 1 $75M
TOTAL $315M
Largest Alydia Health, Inc.
$240M (2021-06-16)

 Subscribe to unlock this and 201,888
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.